These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1479169)

  • 1. Halitosis and Helicobacter pylori. A possible link?
    Tiomny E; Arber N; Moshkowitz M; Peled Y; Gilat T
    J Clin Gastroenterol; 1992 Oct; 15(3):236-7. PubMed ID: 1479169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial.
    Hosking SW; Ling TK; Chung SC; Yung MY; Cheng AF; Sung JJ; Li AK
    Lancet; 1994 Feb; 343(8896):508-10. PubMed ID: 7906759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicobacter pylori eradication with doxycycline-metronidazole-bismuth subcitrate triple therapy.
    Borody TJ; George LL; Brandl S; Andrews P; Lenne J; Moore-Jones D; Devine M; Walton M
    Scand J Gastroenterol; 1992 Apr; 27(4):281-4. PubMed ID: 1589705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bismuth-based triple therapy with bismuth subcitrate, metronidazole and tetracycline in the eradication of Helicobacter pylori: a randomized, placebo controlled, double-blind study.
    Veldhuyzen Van Zanten S; Farley A; Marcon N; Lahaie R; Archambault A; Hunt R; Bailey R; Owen D; Spénard J; Stiglick A; Aimola N; Colin P
    Can J Gastroenterol; 2000; 14(7):599-602. PubMed ID: 10978947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Randomized Controlled Trial Shows that both 14-Day Hybrid and Bismuth Quadruple Therapies Cure Most Patients with Helicobacter pylori Infection in Populations with Moderate Antibiotic Resistance.
    Tsay FW; Wu DC; Yu HC; Kao SS; Lin KH; Cheng JS; Wang HM; Chen WC; Sun WC; Tsai KW; Hsu PI
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eradicating Helicobacter pylori and symptoms of non-ulcer dyspepsia.
    Patchett S; Beattie S; Leen E; Keane C; O'Morain C
    BMJ; 1991 Nov; 303(6812):1238-40. PubMed ID: 1747644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colloidal bismuth subcitrate in non-ulcer dyspepsia.
    Khanna MU; Abraham P; Nair NG; Mistry FP; Vora IM
    J Postgrad Med; 1992; 38(3):106-8. PubMed ID: 1303406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of three different second-line quadruple therapies including bismuth subcitrate in Turkish patients with non-ulcer dyspepsia who failed to eradicate Helicobacter pylori with a 14-day standard first-line therapy.
    Uygun A; Ozel AM; Yildiz O; Aslan M; Yesilova Z; Erdil A; Bagci S; Gunhan O
    J Gastroenterol Hepatol; 2008 Jan; 23(1):42-5. PubMed ID: 17559359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ranitidine versus colloidal bismuth subcitrate in combination with amoxicillin and metronidazole for eradicating Helicobacter pylori in patients with duodenal ulcer.
    Carpintero P; Blanco M; Pajares JM
    Clin Infect Dis; 1997 Nov; 25(5):1032-7. PubMed ID: 9402352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.
    Liou JM; Fang YJ; Chen CC; Bair MJ; Chang CY; Lee YC; Chen MJ; Chen CC; Tseng CH; Hsu YC; Lee JY; Yang TH; Luo JC; Chang CC; Chen CY; Chen PY; Shun CT; Hsu WF; Hu WH; Chen YN; Sheu BS; Lin JT; Wu JY; El-Omar EM; Wu MS;
    Lancet; 2016 Nov; 388(10058):2355-2365. PubMed ID: 27769562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
    Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK
    Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori eradication treatment reduces the severity of rosacea.
    Utaş S; Ozbakir O; Turasan A; Utaş C
    J Am Acad Dermatol; 1999 Mar; 40(3):433-5. PubMed ID: 10071314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of metronidazole resistance on efficacy of quadruple therapy for Helicobacter pylori eradication.
    van der Hulst RW; van der Ende A; Homan A; Roorda P; Dankert J; Tytgat GN
    Gut; 1998 Feb; 42(2):166-9. PubMed ID: 9536938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic alcoholic gastritis. Roles of alcohol and Helicobacter pylori.
    Uppal R; Lateef SK; Korsten MA; Paronetto F; Lieber CS
    Arch Intern Med; 1991 Apr; 151(4):760-4. PubMed ID: 2012461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Halitosis and Helicobacter pylori: a possible relationship.
    Ierardi E; Amoruso A; La Notte T; Francavilla R; Castellaneta S; Marrazza E; Monno RA; Francavilla A
    Dig Dis Sci; 1998 Dec; 43(12):2733-7. PubMed ID: 9881507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
    Avidan B; Melzer E; Keller N; Bar-Meir S
    Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of colloidal bismuth subcitrate and metronidazole, both in combination with an H2-antagonist as therapy for Helicobacter pylori.
    Baffone W; Belbusti F; Barbieri E; Pianetti A; Bruscolini F; Fabi MT; Salvaggio L; Albano A
    J Chemother; 1997 Jun; 9(3):208-12. PubMed ID: 9210004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
    Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM
    Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic success with bismuth-containing sequential and quadruple regimens in Helicobacter pylori eradication.
    Ozturk O; Doganay L; Colak Y; Yilmaz Enc F; Ulasoglu C; Ozdil K; Tuncer I
    Arab J Gastroenterol; 2017 Jun; 18(2):62-67. PubMed ID: 28601610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.